AlgenScribe
PrivateLast Round
Seed
Nov 22, 2025
Total Funding Raised
$541,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
AlgenScribe is a biotechnology company developing a genome editing platform to improve human health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AlgenScribe Comparables
Compare AlgenScribe with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Integra Therapeutics | 81% | |
| Caszyme | 74% | |
| Mammoth Biosciences | 73% | |
AlgenScribe Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 22, 2025 | ||||
| Grant | Aug 1, 2024 | ||||
| Pre Seed | Jun 5, 2023 |
AlgenScribe Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agence Nationale de la Recherche | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 22, 2025
$541K raised in Seed round.
- Aug 1, 2024
Received grant funding from Agence Nationale de la Recherche.
AlgenScribe Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AlgenScribe's valuation, stock price, and market status.